SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.

SIFI, a leading international ophthalmic company, today announced that its shareholders have signed an agreement, subject to conditions precedent, to sell 100% of SIFI shares to Faes Farma, a leading ...

The campaign ‘Insurance United Against Dementia’ has appointed Marsh McLennan UK CEO, Chris Lay, as its new chairperson.